Publications by authors named "Jason Chandler"

Claim this Profile
O
Operationalization and Use of Bispecific T-Cell-Engaging Antibodies in Community Practices: Multidisciplinary Perspectives on Developing Logistics and Workflow for Cytokine Release Syndrome Management.
William Donnellan, Shih-Wen Lin, Jonathan Abbas, Jesus G Berdeja, Lourenia Cassoli, Jason C Chandler

J Adv Pract Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 Study Evaluating Pharmacokinetics and Tolerability of Ofatumumab Combined With Bendamustine in Patients With Indolent B-Cell Non-Hodgkin's Lymphoma.
Andres Forero-Torres, Jason Claud Chandler, Swaminathan P Iyer, Abraham S Kanate, Michelle Quinlan

Clin Pharmacol Drug Dev· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ib study of combinations of avadomide (CC-122), CC-223, CC-292, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma.
Vincent Ribrag, Julio C Chavez, Carola Boccomini, Jason Kaplan, Jason C Chandler

EJHaem· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ublituximab plus ibrutinib versus ibrutinib alone for patients with relapsed or refractory high-risk chronic lymphocytic leukaemia (GENUINE): a phase 3, multicentre, open-label, randomised trial.
Jeff P Sharman, Danielle M Brander, Anthony R Mato, Nilanjan Ghosh, Stephen J Schuster, Jason C Chandler

Lancet Haematol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Mutations as a Driver of Metastasis Signaling in Advanced Cancer Patients.
Ritu Pandey, Nathan Johnson, Laurence Cooke, Benny Johnson, Yuliang Chen, Jason Chandler

Cancers (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology.
Shaji K Kumar, Natalie S Callander, Kehinde Adekola, Larry Anderson, Muhamed Baljevic, Jason C Chandler

J Natl Compr Canc Netw· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 153.
David M Waterhouse, Edward B Garon, Jason Chandler, Michael McCleod, Maen Hussein

J Clin Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020.
Shaji K Kumar, Natalie S Callander, Jens Hillengass, Michaela Liedtke, Muhamed Baljevic, Jason C Chandler

J Natl Compr Canc Netw· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Efficacy, and Patient-Reported Health-Related Quality of Life and Symptom Burden with Nivolumab in Patients with Advanced Non-Small Cell Lung Cancer, Including Patients Aged 70 Years or Older or with Poor Performance Status (CheckMate 153).
David R Spigel, Michael McCleod, Robert M Jotte, Lawrence Einhorn, Leora Horn, Jason C Chandler

J Thorac Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid Tumors.
David Hong, Drew Rasco, Michael Veeder, Jason J Luke, Jason Chandler

Oncology· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lung.
Brennan McCullar, Manjari Pandey, George Yaghmour, Felicia Hare, Kruti Patel, Jason C Chandler

Breast Cancer Res Treat· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2 Study of the Safety and Tolerability of Nivolumab Plus Crizotinib for the First-Line Treatment of Anaplastic Lymphoma Kinase Translocation - Positive Advanced Non-Small Cell Lung Cancer (CheckMate 370).
David R Spigel, Craig Reynolds, David Waterhouse, Edward B Garon, Jason Chandler

J Thorac Oncol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the effect of dabrafenib and metabolites on QTc interval in patients with BRAF V600-mutant tumours.
Noelia Nebot, Hendrik-Tobias Arkenau, Jeffrey R Infante, Jason C Chandler, Andrew Weickhardt

Br J Clin Pharmacol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety profile of nivolumab administered as 30-min infusion: analysis of data from CheckMate 153.
David Waterhouse, Leora Horn, Craig Reynolds, David Spigel, Jason Chandler

Cancer Chemother Pharmacol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018.
Shaji K Kumar, Natalie S Callander, Melissa Alsina, Djordje Atanackovic, J Sybil Biermann, Jason C Chandler

J Natl Compr Canc Netw· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial.
James L Gulley, Arun Rajan, David R Spigel, Nicholas Iannotti, Jason Chandler

Lancet Oncol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of Rituximab to Chemotherapy Reduced the Rate of Surgery for Gastric-DLBCL Without Increasing Early Mortality.
Philippe Prouet, Smith Giri, Eric Wiedower, Andrew Fintel, George Yaghmour, Jason C Chandler

Anticancer Res· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.
Shaji K Kumar, Natalie S Callander, Melissa Alsina, Djordje Atanackovic, J Sybil Biermann, Jason C Chandler

J Natl Compr Canc Netw· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unusual, spontaneous aneurysm formation in a patient being treated with ibrutinib for chronic lymphocytic leukemia.
Eric Wiedower, Felicia Hare, Adam Arthur, Jason Chandler, Michael G Martin

Ther Adv Hematol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic alterations in neuroendocrine cancers of the ovary.
George Yaghmour, Philippe Prouet, Eric Wiedower, Omer Hassan Jamy, Rebecca Feldman, Jason C Chandler

J Ovarian Res· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lung.
Brennan McCullar, Manjari Pandey, George Yaghmour, Felicia Hare, Kruti Patel, Jason C Chandler

Breast Cancer Res Treat· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comorbidities Drive Outcomes for Both Malignancy-Associated and Non-Malignancy-Associated Hemophagocytic Syndrome.
Benny Johnson, Smith Giri, Sara E Nunnery, Eric Wiedower, Omer Jamy, Jason C Chandler

Clin Lymphoma Myeloma Leuk· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016.
Kenneth C Anderson, Melissa Alsina, Djordje Atanackovic, J Sybil Biermann, Jason C Chandler

J Natl Compr Canc Netw· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Disparities Faced by Undocumented Workers From Low- and Middle-Income Countries in the United States With Hematologic Malignancies.
Sara E Nunnery, Andrew E Fintel, W Clay Jackson, Jason C Chandler, Michael O Ugwueke

J Natl Compr Canc Netw· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Myeloma, Version 2.2016: Clinical Practice Guidelines in Oncology.
Kenneth C Anderson, Melissa Alsina, Djordje Atanackovic, J Sybil Biermann, Jason C Chandler

J Natl Compr Canc Netw· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis